H. Choy

N. Hanna, H. Choy, R. Timmerman, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognosis of adenocarcinoma arising in Barrett's esophagus.

S. Hoff, H. Choy, C. Blanke, 1998, The Annals of thoracic surgery.

Combined modality therapy for esophageal cancer

S. Leach, H. Choy, C. Blanke, 1997 .

Combining radiation and chemotherapy: Current status and future directions

H. Choy, 1997 .

The Role of Gemcitabine in Combined Modality Therapy

H. Choy, W. Blackstock, Gary Y. Yang, 2003 .

Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studies.

C. Obasaju, R. Govindan, P. Iyengar, 2015, Lung cancer.

Radiotherapy and Third Generation Concurrent Chemotherapy Agents

P. Iyengar, H. Choy, R. Bland, 2011 .

Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue

H. Choy, M. Yao, Clinton Park, 2008, Clinical Cancer Research.

Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?

H. Choy, H. Wakelee, N. Saijo, 2008, Clinical lung cancer.

Satraplatin: an orally available platinum analog for the treatment of cancer

H. Choy, 2006, Expert review of anticancer therapy.

Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.

H. Choy, David H. Johnson, Y. Shyr, 2005, International journal of radiation oncology, biology, physics.

Topoisomerase I inhibitors in the combined-modality therapy of lung cancer.

H. Choy, L. C. Cho, L. Cho, 2001, Oncology.

Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer

H. Choy, R. MacRae, 2003, Current oncology reports.

Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting.

H. Choy, E. Vokes, 2003, Lung cancer.

Chemoradiation in Cancer Therapy

H. Choy, B. Teicher, A. Giordano, 2002, Cancer Drug Discovery and Development.

Combined modality therapy for non-small cell lung cancer, past, present, and future.

H. Choy, D. W. Kim, 2003, Lung cancer.

Topoisomerase I inhibitors in the combined modality therapy of lung cancer.

H. Choy, J. S. Kim, H. Pyo, 2001, Clinical lung cancer.

Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer.

H. Choy, R. MacRae, 2001, Oncology.

Taxanes in combined modality therapy for solid tumors.

H. Choy, 2001, Critical reviews in oncology/hematology.

Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer

H. Choy, H. Pyo, R. MacRae, 2001, Expert opinion on pharmacotherapy.

A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial.

H. Choy, David H. Johnson, Y. Shyr, 2000, Clinical lung cancer.

Taxanes in combined-modality therapy for solid tumors.

H. Choy, 1999, Oncology.

The role of radiation, with or without chemotherapy, in the management of NSCLC.

H. Choy, A. Chakravarthy, A. Chakravarthy, 1999, Oncology.

Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.

H. Choy, H. Safran, J. Bogart, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I dose escalation trial using stereotactic body radiation therapy (SBRT) for partial breast irradiation (PBI).

H. Choy, R. Timmerman, A. Leitch, 2015 .

Automated Text Message Reminders Improve Radiation Therapy Compliance.

Steve B. Jiang, A. Christie, K. Westover, 2019, International journal of radiation oncology, biology, physics.

National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists.

H. Choy, David H. Johnson, A. Cmelak, 1999, International journal of radiation oncology, biology, physics.

Radiotherapy Patterns of Care Study in Lung Carcinoma

D. Ettinger, R. Abrams, R. Munden, 2003 .

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

R. Hannan, J. Brugarolas, V. Margulis, 2021, Advances in radiation oncology.

Combinations of Topoisomerase Inhibitors and Ionizing Radiation

H. Choy, M. Bastasch, 2006 .

The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer.

H. Choy, R. MacRae, 2001, Seminars in oncology.

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial

James J. Evans, H. Choy, A. Dicker, 2014, Journal of Neuro-Oncology.

Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation?

H. Choy, E. Gore, 2004, Seminars in radiation oncology.

Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.

John L. Meyer, H. Choy, R. Timmerman, 2011, Frontiers of radiation therapy and oncology.

Efforts in Lung Cancer : Focus on Early-Stage Non – Small-Cell Lung Cancer comprehensive review

H. Choy, H. Wakelee, N. Saijo, 2011 .

Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer

Ashutosh Kumar Singh, Joe Y. Chang, H. Choy, 2019 .

Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.

H. Choy, Y. Shyr, W. Akerley, 2005, Lung cancer.

Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)

Ashutosh Kumar Singh, P. Iyengar, H. Choy, 2016 .

Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant.

H. Choy, Y. Shyr, R. MacRae, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer

R. Hannan, J. Brugarolas, A. Christie, 2020 .

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

H. Choy, R. Arriagada, J. Pignon, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.

H. Choy, Q. Cao, G. Amorino, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.

H. Choy, B. Cole, L. Yee, 1995, Seminars in oncology.

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.

H. Choy, Y. Shyr, D. Johnson, 2001, Lung cancer.

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.

Jeffrey W. Clark, H. Choy, H. Safran, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.

H. Choy, A. Chakravarthy, D. Johnson, 2000, Oncology.

In reply to Zagar and Marks.

P. Okunieff, W. Curran, H. Choy, 2012, International journal of radiation oncology, biology, physics.

Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer: A Phase I Trial

C. Obasaju, R. Govindan, H. Choy, 2010 .

Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical Radiation Oncology.

Radiation-induced KRAS G12V mutant lung adenocarcinoma in a never smoker

H. Choy, D. Gerber, D. Oliver, 2016 .

National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States

R. Mohan, H. Choy, A. Koong, 2022, Frontiers in Oncology.

Pancreatic adenocarcinoma: Adjuvant, neoadjuvant, and intraoperative chemoradiation

S. Leach, H. Choy, C. Blanke, 1997 .

Correlation of HER1/EGFR expression and degree of radiosensitizing effect of the HER1/EGFR-tyrosine kinase inhibitor erlotinib.

H. Choy, D. Saha, P. Mukhopadhyay, 2005, Indian journal of biochemistry & biophysics.

Phase I trial of weekly paclitaxel in advanced lung cancer.

H. Choy, W. Akerley, M. Glantz, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An economic analysis of Radiation Therapy Oncology Group 94-10: cost-efficacy of concurrent vs. sequential chemoradiotherapy

W. Curran, H. Choy, R. Komaki, 2018, Journal of Radiation Oncology.

Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.

Xian-Jin Xie, A. Christie, P. Iyengar, 2015, International journal of radiation oncology, biology, physics.

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.

H. Choy, R. Beauchamp, L. Nanney, 2002, The Journal of surgical research.

Expression in Human Lung Carcinoma Cells-Mediated Induction of Cyclooxygenase-2 β Interleukin-1 The Cyclin-Dependent Kinase 2 Inhibitor Down-regulates

H. Choy, D. Saha, A. Nandi, 2006 .

The Antiangiogenic Agent SU 5416 Down-Regulates Phorbol Ester-Mediated Induction of Cyclooxygenase 2 Expression by Inhibiting Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity 1

J. Morrow, H. Choy, D. Saha, 2003 .

The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity.

J. Morrow, H. Choy, D. Saha, 2003, Cancer research.

Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells.

H. Choy, Q. Cao, D. Saha, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Cyclin-Dependent Kinase 2 Inhibitor Down-regulates Interleukin-1β-Mediated Induction of Cyclooxygenase-2 Expression in Human Lung Carcinoma Cells

H. Choy, D. Saha, P. Mukhopadhyay, 2006 .

Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer.

H. Choy, D. W. Kim, 2004, International journal of radiation oncology, biology, physics.

Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer.

H. Choy, W. Akerley, M. Glantz, 1996, Seminars in oncology.

Combined modality therapy of NCI-H460 human lung cancer using epidermal growth factor receptor inhibitor, OSI-774, and ionizing radiation in vitro and in vivo

H. Choy, J. Kim, D. Saha, 2002 .

P-351 The antiangiogenic agent SU5416 downregulates phorbol ester-mediated induction of cyclooxygenase-2 expression by inhibiting NADPH oxidase

J. Morrow, H. Choy, D. Saha, 2003 .

Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy

H. Choy, G. Amorino, H. Pyo, 2000, Cancer Chemotherapy and Pharmacology.

Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.

H. Choy, M. Egorin, B. Cole, 1996, Seminars in oncology.

Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid‐flow status

W. Hall, H. Choy, B. Chozick, 1995, Cancer.

Management of Locally Advanced Non-small Cell Lung Cancer

H. Choy, Jaeho Cho, P. DeRose, 2009 .

Chemoradiation in NSCLC: focus on the role of gemcitabine.

H. Choy, 2004, Oncology.

Adjuvant and neoadjuvant treatments for NSCLC.

H. Choy, D. Gandara, E. Vokes, 2002, Lung cancer.

Heavy Ions in Cancer Therapy.

M. Durante, H. Choy, A. Pompoš, 2016, JAMA oncology.

International Symposium on Ion Therapy: Planning the First Hospital-Based Heavy Ion Therapy Center in the United States.

Steve B. Jiang, H. Choy, R. Timmerman, 2015, International journal of particle therapy.

DNA topoisomerase I-targeting drugs as radiation sensitizers.

H. Choy, M. Rothenberg, A. Y. Chen, 1999, Oncology.

Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.

J. Minna, G. Scagliotti, R. Govindan, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Standards of care for anemia management in oncology

H. Choy, C. Langer, J. Glaspy, 2002, Cancer.

Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer.

H. Choy, G. Amorino, H. Pyo, 2000, International journal of radiation oncology, biology, physics.

Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions.

H. Choy, M. Egorin, W. Akerley, 1995, Seminars in Oncology.

Concurrent chemotherapy and radiotherapy in patients with brain tumors.

H. Choy, W. Akerley, M. Glantz, 1999, Oncology.

Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer.

R. Hannan, I. Pedrosa, J. Brugarolas, 2022, European urology oncology.

Sustained Metaphase Arrest in Response to Ionizing Radiation in a Non-small Cell Lung Cancer Cell Line

H. Choy, D. Saha, R. Kodym, 2008, Radiation research.

T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer

P. Iyengar, K. Westover, H. Choy, 2022, Advances in Radiation Oncology.

The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells.

H. Choy, Q. Cao, G. Amorino, 2001, International journal of radiation oncology, biology, physics.

A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.

J. Fowler, R. Govindan, H. Choy, 2010, International journal of radiation oncology, biology, physics.

Combined chemoradiation therapy for limited-stage small-cell lung cancer.

D. Ettinger, H. Choy, M. Teng, 1999, Oncology.

Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC

W. Curran, K. Forster, P. Iyengar, 2017 .

Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells.

H. Choy, Y. Shyr, Q. Cao, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients with Locally Advanced Non-small Cell Lung Cancer - An Updated Analysis of RTOG 0214

H. Choy, M. Suntharalingam, L. Gaspar, 2012 .

Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.

T. Tabuchi, H. Choy, I. Miyashiro, 2019, The Lancet. Oncology.

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Anurag K. Singh, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel and concurrent radiation for lung, pancreatic, and gastric carcinomas: Significance of p53 gene mutations for treatment response

H. Choy, H. Safran, W. Akerley, 1997 .

Single-Fraction Carbon Ion Radiotherapy for Early-Stage NSCLC-The Future Is Now.

H. Choy, A. Laine, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): A report of the 2 year and median survival (MS) for the RTOG 0324 trial

W. Curran, H. Choy, R. Komaki, 2008 .

OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC

Anurag K. Singh, P. Iyengar, H. Choy, 2016 .

Radiotherapy (RT) patterns of care study (PCS) in lung carcinoma

D. Ettinger, R. Abrams, R. Munden, 2002 .

Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617

J. Galvin, P. Iyengar, H. Choy, 2015 .

Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story

H. Choy, J. Sloan, J. Bradley, 2013 .

Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine.

H. Choy, E. Vokes, 2005, Lung cancer.

O-263 Randomized 3-arm phase II study of paclitaxel (T), carboplatin (C), and thoracic radiation (TRT) for patients with stage III non-small cell lung cancer (NSCLC). Report of locally advanced multimodality protocol (LAMP) - ACR 427

W. Curran, H. Choy, P. Bonomi, 2003 .

Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.

J. Cadeddu, R. Hannan, I. Pedrosa, 2017, International journal of radiation oncology, biology, physics.

Larry Emanuel Kun, March 10, 1946-May 27, 2018.

T. Merchant, H. Choy, S. Donaldson, 2019, International journal of radiation oncology, biology, physics.

Radiation Therapy Oncology Group (RTOG) Protocol 0915: A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Anurag K. Singh, H. Choy, G. Videtic, 2013 .

Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model.

J. Cadeddu, K. Forster, Y. Lotan, 2006, European urology.

Preoperative cetuximab and radiation (XRT) for patients (pts) with surgically resectable esophageal and gastroesophageal junction (GEJ) carcinomas: A pilot study from the Hoosier Oncology Group and the University of Texas Southwestern.

H. Choy, N. Hanna, C. Becerra, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.

H. Choy, Y. Shyr, P. Mohr, 1999, Seminars in radiation oncology.

Commentary on “Preliminary Report on Reduction of Esophagitis by Amifostinein Patients with Non–Small-Cell Lung Cancer Treated with Chemoradiotherapy”

H. Choy, R. MacRae, 2001 .

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial

J. Galvin, H. Choy, R. Timmerman, 2018, JAMA oncology.

The role of UFT in combined-modality therapy.

H. Choy, C. Blanke, M. Teng, 1999, Oncology.

A Phase III Randomized Study of Image Guided Conventional (60 Gy/30 fx) Versus Accelerated, Hypofractionated (60 Gy/15 fx) Radiation for Poor Performance Status Stage II and III NSCLC Patients—An Interim Analysis

P. Iyengar, K. Westover, H. Choy, 2016 .

Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.

H. Choy, Y. Shyr, D. Johnson, 1997, Seminars in oncology.

Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.

H. Choy, C. Chung, H. Safran, 1996, Seminars in oncology.

Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.

H. Choy, H. Safran, 1995, Seminars in oncology.

Dosimetric uncertainties of three‐dimensional dose reconstruction from two‐dimensional data in a multi‐institutional study

W. Curran, H. Choy, G. Starkschall, 2004, Journal of applied clinical medical physics.

A phase I trial of outpatient weekly irinotecan/carboplatin and concurrent radiation for stage III unresectable non small-cell lung cancer: a Vanderbilt-Ingram Cancer Center Affiliate Network Trial.

H. Choy, A. Chakravarthy, 2000, Clinical lung cancer.

Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial.

H. Choy, H. Safran, W. Sikov, 1997, Seminars in oncology.

Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.

H. Choy, W. Akerley, R. Devore, 1999, Seminars in oncology.

Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas

H. Choy, B. Cole, M. Glantz, 1998, Journal of Neuro-Oncology.

Phase I study of irinotecan (Ir) and cisplatin (DDP) in combination with thoracic radiotherapy (RT), either twice daily (45 Gy) or once daily (70 Gy), in patients with limited (Ltd) small cell lung carcinoma (SCLC): Early analysis of RTOG 0241.

W. Curran, H. Choy, S. Swann, 2006, Journal of Clinical Oncology.

Radiotherapy patterns of care study in lung carcinoma.

D. Ettinger, R. Abrams, R. Munden, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of Practice in Radiation Dose Prescription and Treatment Planning for Patients With Lung Cancer Among Members of American Society of Therapeutic Radiology and Oncology

H. Choy, R. Komaki, H. Sandler, 2007 .

Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer

J. Galvin, H. Choy, R. Timmerman, 2018, JAMA oncology.

Radiation therapy for non-small cell lung cancer (NSCLC).

H. Choy, A. Chakravarthy, J. S. Kim, 2001, Cancer treatment and research.

Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study

P. Iyengar, H. Choy, R. Timmerman, 2014, BMC Cancer.

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

P. Iyengar, K. Westover, H. Choy, 2018, JAMA oncology.

Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors.

H. Choy, E. Zuhowski, M. Egorin, 1995, Journal of the National Cancer Institute.

SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.

H. Choy, D. Saha, A. Habib, 2007, Neoplasia.

Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.

P. Iyengar, H. Choy, R. Timmerman, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.

J. Jett, F. Khuri, H. Choy, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer

P. Iyengar, K. Westover, H. Choy, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.

L. Wilson, H. Choy, M. Suntharalingam, 2012, International journal of radiation oncology, biology, physics.

Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.

A. Bleyer, H. Choy, J. Lee, 2010, Journal of the National Cancer Institute.

Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.

H. Choy, B. Movsas, A. Sun, 2013, International journal of radiation oncology, biology, physics.

RTOG 0017: A Phase I Trial of Concurrent Gemcitabine/Carboplatin or Gemcitabine/Paclitaxel and Radiation Therapy (“Ping-Pong Trial”) Followed By Adjuvant Chemotherapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-small Cell Lung Cancer

D. Ettinger, W. Curran, H. Choy, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.

H. Choy, J. Bradley, Q. Le, 2012, International journal of radiation oncology, biology, physics.

Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?

H. Choy, L. Milas, 2003, Journal of the National Cancer Institute.

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

H. Choy, Q. Cao, G. Amorino, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

J. Galvin, P. Iyengar, H. Choy, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

W. Curran, H. Choy, J. Sloan, 2016, JAMA oncology.

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.

H. Choy, C. Chung, H. Safran, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer.

Hak Choy, H. Choy, David H. Johnson, 2001, The Annals of thoracic surgery.

Epidermal growth factor receptor inhibition in lung cancer: status 2012.

Edward S. Kim, P. Jänne, F. Cappuzzo, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epidermal Growth Factor Receptor Inhibition in Lung Cancer

Edward S. Kim, P. Jänne, F. Cappuzzo, 2013 .

Cooperative group research endeavors in small-cell lung cancer: current and future directions.

H. Choy, N. Saijo, D. Gandara, 2009, Clinical lung cancer.

Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer

H. Choy, K. Choe, T. Nam, 2012, Cancer research and treatment : official journal of Korean Cancer Association.

Novel Substances in the Treatment of Lung Cancer for the Radiation Oncologist

H. Choy, L. C. Cho, L. Cho, 2005 .

Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncology.

P. Iyengar, H. Choy, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Joe Y. Chang, Anurag K. Singh, P. Iyengar, 2017, International journal of radiation oncology, biology, physics.

Enhancement of Radiation Effects In Vitro by the Estrogen Metabolite 2-Methoxyestradiol

H. Choy, G. Amorino, Michael L. Freeman, 2000, Radiation research.

A phase I study with Satraplatin and simultaneous chest radiation for non-small cell lung cancer

P. Iyengar, H. Choy, R. Hughes, 2012 .

Potential for Inhibitors of Cyclooxygenase-2 to Enhance Tumor Radioresponse

H. Choy, A. Dicker, R. Burd, 2003 .

Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.

H. Choy, J. Herndon, E. Vokes, 2005, Clinical lung cancer.

Current Update on the Management of Locally Advanced Non-small Cell Lung Cancer.

H. Choy, Clint Park, B. Chang, 2006 .

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).

H. Choy, Y. Shyr, D. Johnson, 2000, International journal of radiation oncology, biology, physics.

Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.

H. Choy, A. Cmelak, Y. Shyr, 2000, Cancer.

Paclitaxel, carboplatin and radiation therapy for non-small-cell lung cancer.

H. Choy, W. Akerley, R. Devore, 1998, Oncology.

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

K. Forster, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.

H. Choy, M. Suntharalingam, L. Gaspar, 2019, JAMA oncology.

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

Laurentiu M. Pop, L. Cowell, S. Christley, 2021, Clinical Cancer Research.

Management of Locally Advanced Lung Cancer

H. Choy, J. Mendel, 2019, Pulmonary Adenocarcinoma: Approaches to Treatment.

Effect of PF-02341066 and radiation on non-small cell lung cancer cells

Benjamin P. C. Chen, H. Choy, D. Saha, 2012, Oncology reports.

Cetuximab in combination therapy: from bench to clinic

H. Choy, D. Gerber, 2010, Cancer and Metastasis Reviews.

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617

W. Curran, P. Iyengar, H. Choy, 2021, Cancers.

Phase I Study of Concurrent Paclitaxel and Radiation Therapy for Non-Small Cell Lung Cancer

H. Choy, C. Chung, H. Safran, 2012 .

Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer.

H. Choy, Hong-Gyun Wu, 2002, Oncology.

Potential for combined modality therapy of cyclooxygenase inhibitors and radiation.

H. Choy, D. Saha, 2003, Progress in experimental tumor research.

The Role of Cyclooxygenase-2 Inhibitors in Combined Modality Therapy

H. Choy, R. DuBois, H. Pyo, 2003 .

Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.

H. Choy, D. Carbone, G. Amorino, 1999, International Journal of Radiation Oncology, Biology, Physics.

Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.

R. Hannan, J. Brugarolas, V. Margulis, 2019, International journal of radiation oncology, biology, physics.

A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer

J. Morrow, H. Choy, D. Carbone, 2009, Clinical Cancer Research.

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.

R. Govindan, H. Choy, T. Mok, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Phase II Trial of Hippocampal-Sparing Whole Brain Irradiation with Simultaneous Integrated Boost (HSIB-WBRT) for Metastatic Cancer.

R. Hannan, M. Folkert, P. Iyengar, 2020, Neuro-oncology.

Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.

R. Hannan, J. Brugarolas, A. Christie, 2021, European urology oncology.

Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study.

H. Choy, A. Nadeem, H. Safran, 2004, Cancer investigation.

Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical radiation oncology.

Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters.

Steve B. Jiang, Puneeth Iyengar, Jing Wang, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ongoing phase II study of pemetrexed plus carboplatin or cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/b non-small cell lung cancer: Interim update.

C. Obasaju, R. Govindan, H. Choy, 2010 .

A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)

H. Choy, A. Dowlati, A. Sandler, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.

Walter J Curran, Hak Choy, W. Curran, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy for Locally Advanced Nonsmall Cell Lung Cancer Including Combined Modality

H. Choy, P. Houtte, K. Kubota, 2018 .

Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.

W. Curran, H. Choy, R. Herbst, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma

Benjamin Movsas, Walter J. Curran, Hak Choy, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy

R. Hannan, J. Brugarolas, A. Christie, 2018, Oncoimmunology.

Combining taxanes with radiation for solid tumors

H. Choy, 2000, International journal of cancer.

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancer.

H. Choy, L. C. Cho, J. Dowell, 2005, Seminars in oncology.

Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.

J. Berlin, S. Leach, H. Choy, 2005, International journal of radiation oncology, biology, physics.

Synergistic effects of taxol/taxotere on radiation sensitivity on human tumor cell lines

H. Choy, S. Hilsenbeck, D. D. Hoff, 1992 .

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas.

H. Choy, E. Stopa, E. Zuhowski, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Principles and Applications of Chemoirradiation

H. Choy, L. C. Cho, D. Garwood, 2006 .

Chemotherapy and irradiation interaction.

H. Choy, D. W. Kim, 2003, Seminars in oncology.

Irinotecan and radiation in combined-modality therapy for solid tumors.

H. Choy, R. MacRae, H Choy, 2001, Oncology.

A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas.

J. Berlin, H. Choy, Y. Shyr, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Single-agent paclitaxel and radiation for non-small cell lung cancer.

H. Choy, W. Akerley, 1999, Seminars in Radiation Oncology.

Concurrent paclitaxel and thoracic radiation for advanced non-small cell lung cancer.

H. Choy, W. Akerley, 1995, Lung cancer.

Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus

R. Hannan, I. Pedrosa, J. Brugarolas, 2015, Cancer biology & therapy.

EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324.

W. Curran, H. Choy, F. Hirsch, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Enhancement of Tumor Oxygenation and Radiation Response by the Allosteric Effector of Hemoglobin, RSR13

H. Choy, C. Paschal, Y. Shyr, 2001, Radiation research.

Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)

W. Curran, P. Iyengar, H. Choy, 2017 .

Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer.

H. Choy, H. Wakelee, N. Saijo, 2008, Clinical lung cancer.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Contemporary Fractionation Trends within a Large United States Academic Radiation Oncology Department

H. Choy, R. Timmerman, A. Pompoš, 2018, International Journal of Radiation Oncology, Biology, Physics.

A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.

Xian-Jin Xie, M. Folkert, P. Iyengar, 2019, International journal of radiation oncology, biology, physics.

A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer (RTOG 0214): How to Improve Accrual to an Important Prospective Randomized Study

H. Choy, A. Bezjak, J. Waldron, 2005 .

Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer

H. Choy, R. Komaki, K. Bae, 2009 .

Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations.

H. Choy, M. Glantz, L. Yee, 1997, Seminars in oncology.

Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer.

K. Westover, H. Choy, A. Laine, 2014, Seminars in oncology.

A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617.

W. Curran, K. Forster, H. Choy, 2013 .

DNA-PKcs-dependent modulation of cellular radiosensitivity by a selective cyclooxygenase-2 inhibitor.

David J. Chen, Benjamin P. C. Chen, H. Choy, 2007, International journal of radiation oncology, biology, physics.

The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Analysis of Radiation Therapy Oncology Group Trials

W. Curran, J. Coyne, H. Choy, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Meta-analysis of Radiation Therapy Oncology Group (RTOG) Trials

W. Curran, J. Coyne, H. Choy, 2009 .

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer

Hak Choy, Geoffrey Ibbott, William Straube, 2006, Acta oncologica.

Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer

C. Obasaju, R. Govindan, H. Choy, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization.

H. Choy, S. Burma, B. Mukherjee, 2010, Seminars in radiation oncology.

B3-07: A phase II study of Cetuximab (C225) in combination with chemoradiation

W. Curran, H. Choy, R. Komaki, 2007 .

RTOG 0229: A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and Full Dose Radiotherapy (XRT) followed by Resection and Consolidative Therapy for LA-NSCLC

H. Choy, M. Suntharalingam, M. Edelman, 2010 .

Chemoradiation: Biological Principles and Perspectives

H. Choy, R. MacRae, 2002 .

A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck

H. Choy, Yang Xie, L. Nedzi, 2017, Cancer investigation.

Role of paclitaxel in combined modality therapy for locally advanced non-small cell lung cancer (NSCLC): Multiinstitutional trials exploring sequential phase II studies of paclitaxel +/− carboplatin and radiation therapy (+/−hyperfractionation: HFXRT)

H. Choy, Douglas B. Johnson, W. Akerley, 2000 .

Paclitaxel as a radiation sensitizer in non-small cell lung cancer.

H. Choy, M. Browne, 1995, Seminars in oncology.

Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213.

Benjamin Movsas, Hak Choy, Kyounghwa Bae, 2011, Clinical lung cancer.

Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.

H. Choy, H. Wakelee, B. Loo, 2009, Clinical lung cancer.

A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214.

H. Choy, L. Gaspar, K. Bae, 2009, Journal of Clinical Oncology.

Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.

D. Ettinger, W. Curran, H. Choy, 2012, International journal of radiation oncology, biology, physics.

Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.

S. Leach, H. Choy, R. Beauchamp, 1999, Seminars in Radiation Oncology.

The combination of radiation therapy and immunotherapy for genitourinary cancer treatment: rationale, current evidence, and prospects

R. Hannan, P. Iyengar, H. Choy, 2015, Journal of Radiation Oncology.

Localization accuracy and immobilization effectiveness of a stereotactic body frame for a variety of treatment sites.

T. Solberg, P. Iyengar, H. Choy, 2013, International journal of radiation oncology, biology, physics.

Improving Treatment Options for Brain Metastases From ALK-Positive Non-Small-Cell Lung Cancer.

H. Choy, Z. Wardak, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution.

H. Choy, R. Timmerman, You Zhang, 2022, Practical radiation oncology.

RTOG 0324: A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients with stage IIIA/B non-small cell lung cancer (NSCLC)--Association between EGFR gene copy number and patients' outcome

W. Curran, H. Choy, F. Hirsch, 2008 .

Accurate real time localization tracking in a clinical environment using Bluetooth Low Energy and deep learning

Jing Wang, Steve B. Jiang, Weiguo Lu, 2017, PloS one.

Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients

J. Galvin, H. Choy, R. Timmerman, 2007 .

APhase II Study of Celecoxib in Combinationwith Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/BNon^Small Cell Lung Cancer

J. Morrow, H. Choy, D. Carbone, 2009 .

P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

J. Fowler, R. Govindan, H. Choy, 2005 .

Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.

J. Cadeddu, R. Hannan, J. Brugarolas, 2021 .

The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.

H. Choy, D. Saha, P. Mukhopadhyay, 2006, Cancer research.

Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium.

D. Hallahan, H. Choy, G. Mcmahon, 2004, International journal of radiation oncology, biology, physics.

A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial

W. Curran, H. Choy, R. Komaki, 2005 .

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial

W. Curran, H. Choy, R. Komaki, 2005 .

COX-2 Inhibitor as a Radiation Enhancer: New Strategies for The Treatment of Lung Cancer

H. Choy, D. Saha, H. Pyo, 2003, American journal of clinical oncology.

Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214

H. Choy, L. Gaspar, K. Bae, 2009 .

Toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small cell lung cancer (LSCLC) (RTOG 0239)

D. Ettinger, H. Choy, J. Bradley, 2007 .

International Journal of Radiation Oncology Biology Physics: Introduction

Hak Choy, H. Choy, 2004 .

A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell Lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303): An interim report of toxicity and response

A. Bleyer, H. Choy, R. Herbst, 2005 .

Concurrent Paclitaxel and Radiation Therapy for Solid Tumors.

Chung, H. Choy, C. Chung, 1996, Cancer control : journal of the Moffitt Cancer Center.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of Thoracic Oncology.

R. Govindan, H. Choy, T. Mok, 2016, Journal of Clinical Oncology.

Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma

W. Curran, H. Choy, J. Bradley, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combination chemoradiotherapy with gemcitabine: potential applications.

H. Choy, 2000, Oncology.

Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer.

H. Choy, H. Wakelee, N. Saijo, 2008, Clinical lung cancer.

Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer

Zhiguo Zhou, Jing Wang, M. Folkert, 2017, Physics in medicine and biology.

Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.

A. Bleyer, H. Choy, R. Herbst, 2010, Journal of the National Cancer Institute.

A pilot study using kernelled support tensor machine for distant failure prediction in lung SBRT

Jing Wang, Bin Li, Steve B. Jiang, 2018, Medical Image Anal..

Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.

K. Forster, Y. Lotan, Wareef Kabbani, 2006, The Journal of urology.

Optimizing chemoradiation in locally advanced non-small-cell lung cancer.

W. Curran, H. Choy, 2001, Oncology.

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.